JPMorgan Chase & Co’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$686K Sell
34,490
-223,417
-87% -$4.44M ﹤0.01% 3918
2025
Q1
$4.36M Sell
257,907
-213,352
-45% -$3.61M ﹤0.01% 2760
2024
Q4
$8.7M Buy
471,259
+133,215
+39% +$2.46M ﹤0.01% 2344
2024
Q3
$7.35M Buy
338,044
+179,477
+113% +$3.9M ﹤0.01% 2384
2024
Q2
$3.11M Sell
158,567
-61
-0% -$1.2K ﹤0.01% 2814
2024
Q1
$3.44M Sell
158,628
-176,775
-53% -$3.84M ﹤0.01% 2807
2023
Q4
$9.7M Buy
335,403
+45,661
+16% +$1.32M ﹤0.01% 2126
2023
Q3
$7.75M Sell
289,742
-13,926
-5% -$372K ﹤0.01% 2154
2023
Q2
$11.2M Sell
303,668
-38,938
-11% -$1.44M ﹤0.01% 1961
2023
Q1
$10.7M Buy
342,606
+4,870
+1% +$152K ﹤0.01% 1952
2022
Q4
$10.1M Buy
337,736
+144,660
+75% +$4.31M ﹤0.01% 1906
2022
Q3
$7.36M Buy
193,076
+110,804
+135% +$4.22M ﹤0.01% 2074
2022
Q2
$4.49M Buy
82,272
+3,815
+5% +$208K ﹤0.01% 2457
2022
Q1
$4.9M Buy
78,457
+59,711
+319% +$3.73M ﹤0.01% 2575
2021
Q4
$1.89M Sell
18,746
-394,833
-95% -$39.7M ﹤0.01% 3272
2021
Q3
$37.2M Buy
413,579
+81,322
+24% +$7.31M ﹤0.01% 1203
2021
Q2
$30.6M Buy
332,257
+163,907
+97% +$15.1M ﹤0.01% 1340
2021
Q1
$16.3M Buy
168,350
+51,034
+44% +$4.93M ﹤0.01% 1758
2020
Q4
$6.11M Buy
117,316
+107,845
+1,139% +$5.62M ﹤0.01% 2279
2020
Q3
$396K Buy
9,471
+1,106
+13% +$46.2K ﹤0.01% 3472
2020
Q2
$134K Buy
+8,365
New +$134K ﹤0.01% 3845
2020
Q1
Sell
-9,176
Closed -$118K 4699
2019
Q4
$118K Buy
9,176
+1,774
+24% +$22.8K ﹤0.01% 3970
2019
Q3
$76K Buy
+7,402
New +$76K ﹤0.01% 4083
2018
Q1
Sell
-2,943
Closed -$13K 4721
2017
Q4
$13K Sell
2,943
-889
-23% -$3.93K ﹤0.01% 4459
2017
Q3
$18K Buy
+3,832
New +$18K ﹤0.01% 3973
2017
Q2
Sell
-2,561
Closed -$28K 4381
2017
Q1
$28K Sell
2,561
-4,244
-62% -$46.4K ﹤0.01% 4054
2016
Q4
$79K Buy
+6,805
New +$79K ﹤0.01% 3934